A rating of 88 puts Acer Therapeutics Inc (ACER) near the top of the Biotechnology industry according to InvestorsObserver. Acer Therapeutics Inc's score of 88 means it scores higher than 88% of stocks in the industry. Acer Therapeutics Inc also received an overall rating of 72, putting it above 72% of all stocks. Biotechnology is ranked 32 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Acer Therapeutics Inc Stock Today?
Acer Therapeutics Inc (ACER) stock is trading at $3.65 as of 11:48 AM on Friday, Jan 22, a loss of -$0.07, or -1.88% from the previous closing price of $3.72. The stock has traded between $3.39 and $3.70 so far today. Volume today is light. So far 344,395 shares have traded compared to average volume of 1,326,749 shares.
Click Here to get the full Stock Score Report on Acer Therapeutics Inc (ACER) Stock.
